Clinical TrialsBiogen’s Diranersen Falls Short on Primary Goal Yet Signals a Breakthroug... Biogen’s Diranersen Falls Short on Primary Goal Yet Signals a Breakthroug... Read Post »
Clinical TrialsEyePoint Confirms Favorable Safety Profile for DURAVYU in Phase 3 Wet AMD T... EyePoint Confirms Favorable Safety Profile for DURAVYU in Phase 3 Wet AMD T... Read Post »
Clinical TrialsREGENXBIO Delivers Positive Results for Duchenne Therapy RGX-202 REGENXBIO Delivers Positive Results for Duchenne Therapy RGX-202 Read Post »
Clinical TrialsShionogi Builds a New COVID-19 Defense Line With Positive Phase 3 Ensitrelv... Shionogi Builds a New COVID-19 Defense Line With Positive Phase 3 Ensitrelv... Read Post »
New Drug ApprovalTaiho’s INQOVI With Venetoclax Approved for Patients Unable to Receive In... Taiho’s INQOVI With Venetoclax Approved for Patients Unable to Receive In... Read Post »
New Drug ApprovalBeOne Gains FDA Accelerated Approval for BEQALZI in MCL BeOne Gains FDA Accelerated Approval for BEQALZI in MCL Read Post »
New Drug ApprovalEuropean Commission Approves Pfizer’s HYMPAVZI for Haemophilia Patients European Commission Approves Pfizer’s HYMPAVZI for Haemophilia Patients Read Post »
Clinical TrialsEncoded Presents Positive POLARIS Data for ETX101 in Dravet Syndrome Encoded Presents Positive POLARIS Data for ETX101 in Dravet Syndrome Read Post »
Clinical TrialsKura Oncology and Kyowa Kirin Report Updated Frontline Data from KOMET-007 ... Kura Oncology and Kyowa Kirin Report Updated Frontline Data from KOMET-007 ... Read Post »
Clinical TrialsNovo Nordisk Reports Up to 21.6% Weight Loss with Oral Wegovy in OASIS 4 An... Novo Nordisk Reports Up to 21.6% Weight Loss with Oral Wegovy in OASIS 4 An... Read Post »
Clinical TrialsAstellas’s IZERVAY Reduced Risk of Driving Eligibility Loss in Geogra... Astellas’s IZERVAY Reduced Risk of Driving Eligibility Loss in Geogra... Read Post »
Clinical TrialsLilly Reports Long-Term Weight Maintenance Data for Foundayo and Zepbound a... Lilly Reports Long-Term Weight Maintenance Data for Foundayo and Zepbound a... Read Post »
Clinical TrialsAlnylam Reports Consistent HELIOS-B Benefits of Vutrisiran in ATTR-CM Alnylam Reports Consistent HELIOS-B Benefits of Vutrisiran in ATTR-CM Read Post »
Clinical TrialsNovo Nordisk Presents New Wegovy Menopause Data at ECO 2026 Novo Nordisk Presents New Wegovy Menopause Data at ECO 2026 Read Post »
Clinical TrialsBridgeBio Files FDA NDA for Encaleret in Rare Calcium Disorder BridgeBio Files FDA NDA for Encaleret in Rare Calcium Disorder Read Post »
Clinical TrialsAstraZeneca Pushes Eneboparatide Forefront in Hypoparathyroidism with CALYP... AstraZeneca Pushes Eneboparatide Forefront in Hypoparathyroidism with CALYP... Read Post »
Clinical TrialsNovo Nordisk Shows 27.7% Weight Loss With Higher-Dose Wegovy in STEP UP Tri... Novo Nordisk Shows 27.7% Weight Loss With Higher-Dose Wegovy in STEP UP Tri... Read Post »
Clinical TrialsCytokinetics Unveils New MYQORZO Clinical and Real-World Data at ESC 2026 Cytokinetics Unveils New MYQORZO Clinical and Real-World Data at ESC 2026 Read Post »
Drugs Safety AlertMHRA Reinforces Safety Advice for Men Taking Finasteride and Dutasteride MHRA Reinforces Safety Advice for Men Taking Finasteride and Dutasteride Read Post »
ResearchFibroBiologics Advancing Development of a Fibroblast Treatment for Hantavir... FibroBiologics Advancing Development of a Fibroblast Treatment for Hantavir... Read Post »
Clinical TrialsBridgeBio Presents New ATTRibute-CM Data Supporting Acoramidis at Heart Fai... BridgeBio Presents New ATTRibute-CM Data Supporting Acoramidis at Heart Fai... Read Post »
Clinical TrialsViiV Advances Paediatric HIV Care with Dovato Submissions to EMA and FDA ViiV Advances Paediatric HIV Care with Dovato Submissions to EMA and FDA Read Post »
New Drug ApprovalHenlius Secures EU Approval for Serplulimab in Lung and Esophageal Cancers Henlius Secures EU Approval for Serplulimab in Lung and Esophageal Cancers Read Post »
New Drug ApprovalFDA Approves Bizengri for Rare NRG1-Positive Cholangiocarcinoma FDA Approves Bizengri for Rare NRG1-Positive Cholangiocarcinoma Read Post »
New Drug ApprovalFDA Approves VYVGART for All Adult gMG Antibody Subtypes FDA Approves VYVGART for All Adult gMG Antibody Subtypes Read Post »
New Drug ApprovalGenentech Wins FDA Approval for Ocrevus in Pediatric Multiple Sclerosis Genentech Wins FDA Approval for Ocrevus in Pediatric Multiple Sclerosis Read Post »
Clinical TrialsAtsena Presents Encouraging Long-Term Data in XLRS and LCA1 Atsena Presents Encouraging Long-Term Data in XLRS and LCA1 Read Post »
New Drug ApprovalEU Clears BMS’s Sotyktu for Adults With Psoriatic Arthritis EU Clears BMS’s Sotyktu for Adults With Psoriatic Arthritis Read Post »
New Drug ApprovalInnovent Wins NMPA Approval for Multi-Dose Mazdutide Pen in Type 2 Diabetes Innovent Wins NMPA Approval for Multi-Dose Mazdutide Pen in Type 2 Diabetes Read Post »
New Drug ApprovalNICE Recommends Givinostat for Ambulant DMD Patients Aged 6+ via NHS Innova... NICE Recommends Givinostat for Ambulant DMD Patients Aged 6+ via NHS Innova... Read Post »
New Drug ApprovalMHRA Authorizes Dawnzera for Patients With Hereditary Angioedema MHRA Authorizes Dawnzera for Patients With Hereditary Angioedema Read Post »
ResearchJohnson & Johnson Pushes for Full Depression Recovery Through Generatio... Johnson & Johnson Pushes for Full Depression Recovery Through Generatio... Read Post »
Clinical TrialsFDA Clears NRX-101 Study in Treatment-Resistant Depression and Suicidality FDA Clears NRX-101 Study in Treatment-Resistant Depression and Suicidality Read Post »
Clinical TrialsEntrada Strengthens Its Duchenne Pipeline With Positive ENTR-601-44 Study R... Entrada Strengthens Its Duchenne Pipeline With Positive ENTR-601-44 Study R... Read Post »
Clinical TrialsIncyte Shows Durable 24-Week Response With Opzelura in Moderate AD Incyte Shows Durable 24-Week Response With Opzelura in Moderate AD Read Post »
Clinical TrialsMirum Plans NDA Submission After Positive Volixibat PSC Results Mirum Plans NDA Submission After Positive Volixibat PSC Results Read Post »
ResearchNeurocrine Builds a New Roadmap for Physiologic Steroid Dosing in CAH Neurocrine Builds a New Roadmap for Physiologic Steroid Dosing in CAH Read Post »
ResearchNeurocrine Exposes the Silent Workplace Impact of Tardive Dyskinesia Neurocrine Exposes the Silent Workplace Impact of Tardive Dyskinesia Read Post »
Clinical TrialsJohnson & Johnson Breaks a Two-Decade Silence in Perianal Crohn’s Dis... Johnson & Johnson Breaks a Two-Decade Silence in Perianal Crohn’s Dis... Read Post »
New Drug ApprovalBridgeBio Gains ANVISA Clearance in Brazil for BEYONTTRA in ATTR-CM BridgeBio Gains ANVISA Clearance in Brazil for BEYONTTRA in ATTR-CM Read Post »
Clinical TrialsAbbVie Sharpens Its IBD Edge With Real-World SKYRIZI and RINVOQ Results AbbVie Sharpens Its IBD Edge With Real-World SKYRIZI and RINVOQ Results Read Post »
Clinical TrialsCytokinetics Shifts the Hypertrophic Landscape: Aficamten Scores in ACACIA ... Cytokinetics Shifts the Hypertrophic Landscape: Aficamten Scores in ACACIA ... Read Post »
Clinical TrialsViridian Therapeutics Tightens Grip on TED Pipeline With REVEAL-2 Milestone Viridian Therapeutics Tightens Grip on TED Pipeline With REVEAL-2 Milestone Read Post »
Clinical TrialsOncolytics Biotech Reports Strong Early Data for Pelareorep in mCRC Oncolytics Biotech Reports Strong Early Data for Pelareorep in mCRC Read Post »
Clinical TrialsLilly Drives Long-Term Stability in UC with Omvoh LUCENT-3 Findings Lilly Drives Long-Term Stability in UC with Omvoh LUCENT-3 Findings Read Post »
Clinical TrialsJohnson & Johnson Doubles Down on IBD Inflammation with Dual-Target The... Johnson & Johnson Doubles Down on IBD Inflammation with Dual-Target The... Read Post »
Clinical TrialsRegeneron and Sanofi Confirm Dupixent Benefits in Eosinophilic Esophagitis Regeneron and Sanofi Confirm Dupixent Benefits in Eosinophilic Esophagitis Read Post »
New Drug ApprovalASCENIV Approved for Expanded Pediatric Use in Primary Immunodeficiency ASCENIV Approved for Expanded Pediatric Use in Primary Immunodeficiency Read Post »
Clinical TrialsNetwork Analysis Shows CAPLYTA Favored in Adjunctive MDD Treatment Network Analysis Shows CAPLYTA Favored in Adjunctive MDD Treatment Read Post »
Clinical TrialsTakeda’s TAK-881 delivers comparable results to HYQVIA in PID Takeda’s TAK-881 delivers comparable results to HYQVIA in PID Read Post »
